HLE Glascoat FY26 Revenue Jumps 32% to ₹1,353 Cr; Profit Dips

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
HLE Glascoat FY26 Revenue Jumps 32% to ₹1,353 Cr; Profit Dips

HLE Glascoat reported a 32% rise in FY26 revenue to ₹1,353 crore, driven by its diverse business verticals. However, net profit saw an 8.4% decline to ₹56.6 crore due to integration costs and margin pressures. Debt reduced to ₹348 crore.

HLE Glascoat Sees Strong Revenue Growth, Profit Moderates in FY26

Consolidated Operating Income: ₹1,353 crore
PAT: ₹56.6 crore

Reader Takeaway: Strong revenue growth offset by margin pressure and acquisition integration costs.

What just happened

HLE Glascoat reported a significant 31.7% increase in consolidated operating income to ₹1,353 crore for the fiscal year 2026, compared to ₹1,027.6 crore in FY2025. This growth was fueled by its glass-lined equipment (GLE), filtration and drying (F&D), and heat transfer equipment segments.

However, the company's profitability faced headwinds. Profit After Tax (PAT) declined by 8.4% to ₹56.6 crore in FY2026, down from ₹61.8 crore in the previous year. The EBITDA margin also contracted by 2.7 percentage points to 10.3% in FY2026 from 13.0% in FY2025.

Why this matters

The revenue growth indicates strong demand and market penetration for HLE Glascoat's products. The decline in profit and margins, however, signals challenges that investors need to monitor. These include integration costs from the recently acquired Omeras business and pressure within the domestic GLE segment.

The backstory

HLE Glascoat has been expanding its product portfolio and geographical reach through strategic acquisitions. The company has focused on strengthening its balance sheet by reducing debt and improving its interest coverage ratio.

What changes now

The company is looking to leverage its robust order book of ₹682 crore as of March 31, 2026, to drive growth in FY2027. Management expects continued demand from sectors like pharmaceuticals, specialty chemicals, and oil & gas.

Risks to watch

Key concerns include the impact of integration costs from the Omeras acquisition on future profitability and the ongoing margin pressure in the domestic GLE business. Managing working capital efficiently remains crucial for this capital-intensive business.

Peer comparison

(No peer comparison data available in the filing).

Context metrics (time-bound)

  • Consolidated Operating Income FY2026: ₹1,353 crore (up 31.7% from FY2025)
  • PAT FY2026: ₹56.6 crore (down 8.4% from FY2025)
  • EBITDA Margin FY2026: 10.3% (down from 13.0% in FY2025)
  • Total Debt (Mar 31, 2026): ₹348 crore (down from ₹381 crore in FY2025)
  • Order Book (Mar 31, 2026): ₹682 crore

What to track next

Investors will be watching the company's ability to successfully integrate the Omeras business and improve its profit margins in the upcoming fiscal year. Monitoring order inflows and execution will be key.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.